Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2528237 | Clinical Therapeutics | 2011 | 11 Pages |
Abstract
Dronedarone was used mostly in compliance with PI and risk evaluation and mitigation strategy in the studied population. In the LabRx database, dronedarone was commonly dispensed to patients with cardiovascular risk factors and rarely dispensed to patients with contraindications such as worsening HF or hospitalization for HF or with concomitant prescriptions of potent CYP3A4 inhibitors, QT-prolonging drugs, or both.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shujun MD, MPH, PhD, Juhaeri PhD, Heather A. PharmD, MBA, Andrew T. MD, Wanju S. MD,